# Live Attenuated ETEC Vaccine ACE527 With and Without dmLT Adjuvant in Adults

> **NCT01739231** · PHASE1,PHASE2 · COMPLETED · sponsor: **PATH** · enrollment: 81 (actual)

## Conditions studied

- Diarrhea

## Interventions

- **BIOLOGICAL:** ACE527
- **BIOLOGICAL:** dmLT
- **BIOLOGICAL:** CeraVacx placebo
- **BIOLOGICAL:** H10407 challenge strain

## Key facts

- **NCT ID:** NCT01739231
- **Lead sponsor:** PATH
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-09
- **Primary completion:** 2013-10
- **Final completion:** 2014-01
- **Target enrollment:** 81 (ACTUAL)
- **Last updated:** 2019-02-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01739231

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01739231, "Live Attenuated ETEC Vaccine ACE527 With and Without dmLT Adjuvant in Adults". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01739231. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*